Bio4Dreams reaffirms its commitment as a member of the organizing committee of EuroBioHighTech 2025, the annual event dedicated to BioHighTech, Digital HighTech, and Energy HighTech.

Now in its tenth edition, the event will take place from September 25–27, 2025, in Trieste, as part of Trieste Next – the Festival of Scientific Research.

As a member of the BioHighTech Net 4.0 network, Bio4Dreams is co-organizing the initiative together with Confindustria Alto Adriatico, the Venezia Giulia Chamber of Commerce, BIC Incubatori FVG, and Polo Tecnologico Alto Adriatico.

The main theme will be “Health Technology Assessment for Innovation”, featuring a rich program of conferences and roundtables for institutions, businesses, universities, and investors.

On September 25, at the Urban Center in Trieste, Elisabetta Borello, Co-Founder and VP Strategy & External Relations at Bio4Dreams, will join the opening remarks and co-chair the session on private finance, bringing the incubator’s perspective on early-stage investments. The same day will also feature ChemiCare and Feature Jam, two innovative SMEs incubated within the Bio4Dreams ecosystem, contributing to panels on healthcare technology assessment.

On September 26, in Piazza Unità d’Italia, Marco Dal Ferro, FVG Ecosystem Manager at Bio4Dreams, will take part in the talk on financial support for university training in clinical and biomedical engineering, sharing insights and opportunities to strengthen the regional innovation ecosystem.

“EuroBioHighTech in Trieste is celebrating an important milestone this year: for the past 10 years, it has been a key event for all those looking at innovation and research in the biomedical, biotechnological, and bioinformatics fields.
For many years, Bio4Dreams has been among the organizing institutions, bringing its contribution both through hands-on experience alongside emerging startups in the bio-high-tech sectors and through its long-term strategic vision in this domain. This year’s focus on the new European HTA Regulation, in force since January 2025, will allow us to explore this strategic topic in depth. The regulation will gradually introduce a pan-European approach to the assessment of health technologies (including pharmaceuticals, medical devices, and advanced therapies), with the aim of improving patient access to innovative treatments, strengthening collaboration among Member States, and streamlining authorization procedures. Our thanks go to Eng. Diego Bravar, President of the EuroBioHighTech Organizing Committee: 10 years of dedication, commitment, and passion for a driving sector of our country’s economy, with Trieste at the heart of international scientific and healthcare innovation!”

Elisabetta Borello, Co-founder, VP Strategy & External Relations of Bio4Dreams

📋 Discover the full program of EuroBioHighTech 2025

📋 See the press release.